Monoclonal Antibody therapy is an intravenous infusion performed over 1 hour with observation for 1 hour afterward. Patients must meet the criteria for therapy, have a signed physician’s order, and be scheduled through our Central Scheduling Department (304) 766-3726.
Antibody treatment can be used by people with mild to moderate COVID-19 who:
- Test positive for SARS-CoV-2.
- Are within 10 days of the start of their symptoms.
- Are age 12 or older and weigh at least 88 pounds.
- Are at high risk of getting very sick from COVID-19 or of needing to be admitted to a hospital because of COVID-19.
- For questions about whether you can and should get antibody treatment, call your doctor or health care provider.
Who is considered high-risk?
High risk for progressing to severe COVID-19 and/or hospitalization is defined as patients who meet at least one of the following criteria:
- Have a body mass index (BMI) greater than 35.
- Have chronic kidney disease.
- Have diabetes.
- Have immunosuppressive disease.
- Are currently receiving immunosuppressive treatment.
- Are 65 years of age or older.
- Are 55 years of age or older AND have one or more of the following:
- Cardiovascular disease.
- Chronic obstructive pulmonary disease/other chronic respiratory disease.
- Are 12-17 years of age AND have one or more of the following:
- Body mass index greater than 85th percentile for their age and gender, based on CDC: Clinical Growth Charts.
- Sickle cell disease.
- Congenital or acquired heart disease.
- Neurodevelopmental disorders, for example, cerebral palsy.
- A medical-related technological dependence; for example, tracheostomy, gastrostomy, or positive pressure ventilation (not related to COVID-19).
- Asthma, reactive airway, or other chronic respiratory disease that requires daily medication for control.
Who should not get antibody treatment?
The treatment should not be used for patients who:
- Are hospitalized due to COVID-19.
- Need oxygen therapy due to COVID-19.
- Those on chronic oxygen therapy due to underlying conditions not related to COVID-19 who need to increase in their baseline oxygen due to COVID-19.
- The antibody treatment may make these conditions worse.